Mussel-inspired bioactive surface coating composition generating silica nanoparticles
US-9801972-B2 · Oct 31, 2017 · US
Antibodies that specifically bind to DRG11-responsive (dragon) proteins
US9416177B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9416177-B2 |
| Application number | US-201414307250-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 17, 2014 |
| Priority date | Apr 18, 2002 |
| Publication date | Aug 16, 2016 |
| Grant date | Aug 16, 2016 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
This invention features antibodies that specifically bind to a human Dragon family protein.
First claim
Opening claim text (preview).
What is claimed is: 1. An antibody that specifically binds to an amino acid sequence contained within residues 54-72 of the amino acid sequence of SEQ ID NO:8. 2. The antibody of claim 1 , wherein the antibody is monoclonal. 3. The antibody of claim 1 , wherein the antibody is polyclonal. 4. The antibody of claim 1 , wherein the antibody binds to the protein with a dissociation constant of less than 1 μM. 5. The antibody of claim 1 , wherein the antibody binds to the protein with a dissociation constant of less than 100 nM. 6. The antibody of claim 5 , wherein the antibody binds to the protein with a dissociation constant of less than 10 nM. 7. The antibody of claim 6 , wherein the antibody binds to the protein with a dissociation constant of less than 1 nM. 8. The antibody of claim 7 , wherein the antibody binds to the protein with a dissociation constant of less than 100 pM. 9. The antibody of claim 1 , wherein the antibody is detectably labeled.
Assignees
Inventors
Classifications
Drugs for immunological or allergic disorders · CPC title
Antineoplastic agents · CPC title
Drugs for disorders of the cardiovascular system · CPC title
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title
Drugs for disorders of the nervous system · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9416177B2 cover?
- This invention features antibodies that specifically bind to a human Dragon family protein.
- Who is the assignee on this patent?
- Massachusetts Gen Hospital
- What technology area does this patent fall under?
- Primary CPC classification C07K14/43509. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Aug 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).